PTN News

  • Controversies in Pediatric Clinical Trials: PTN Investigators and A Patient Advocate Discuss Controversies in Clinical Trials June 14, 2023
    In late April, the Pediatric Trials Network (PTN) sponsored a session at the Pediatric Academic Societies (PAS) Annual Meeting in Washington, D.C. The event involved quick debates between PTN investigators and collaborators on topics related to pediatric clinical research. A patient advocate and student with experience participating in pediatric clinical research shared her thoughts on ...
  • Investigator Spotlight: Dr. Matthew Laughon April 6, 2023
    Q: Could you tell us about yourself (background, areas of interest, expertise, etc.)? I am a neonatologist at The University of North Carolina at Chapel Hill (UNC). I work with the PTN to conduct clinical pharmacology studies in the premature infants in the Neonatal Intensive Care Unit (NICU). Most drugs used in the NICU are “off-label”, ...
  • PTN Will Hold Rapid-Fire Debate During Annual PAS Meeting March 28, 2023
    The Pediatric Academic Society (PAS) meeting is scheduled to take place April 27 – May 1  in Washington, D.C. Investigators from The Pediatric Trials Network (PTN) will sponsor an ancillary event, featuring a rapid-fire debate focused on controversies in pediatric clinical trials. The PTN event will take place Saturday, April 29, from 12:30 p.m. – 2:00 ...
  • 2021/2022 PTN Annual Review Now Available March 9, 2023
    The 2021/2022 PTN Annual Report is now available. Click here to access. A message from PTN leadership:  In 2022, the Pediatric Trials Network (PTN) carried out its mission to improve health for all children by performing research, engaging participants, and sharing science. To date, the PTN has informed 17 label changes for drugs and devices to include ...
  • PTN Research Informs Rifampin Label Change February 21, 2023
    A PTN pharmacokinetic (PK) study recently contributed to a medication label change for the drug rifampin. This research effort, Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants, contributed pharmacokinetic and dosing data for rifampin. 27 participants were enrolled. Overall, a total of 86 plasma concentrations from 22 participants were used to construct the population PK model. Rifampin PK was ...
  • PTN Investigator Spotlight: Dr. Chi Hornik February 13, 2023
    Q: Could you tell us about yourself? What PTN studies are you currently involved with? What are you hoping to learn from the study/studies? A: As a clinical researcher and clinician, I am committed to improving the efficacy and safety of therapeutics in infants, children, and adolescents. To accomplish this goal, I strive to help design ...
  • PTN Video Highlights the Importance of Diversity in Clinical Research February 8, 2023
    In March 2022, the Pediatric Trials Network (PTN) and the International Children’s Advisory Network (iCAN) collaborated to produce a video that discusses the importance of diversity and representation in pediatric clinical research. The video features kids involved with iCAN who have personal experience with clinical trials as well as PTN researchers. They shared why they ...
  • Our Commitment to Thanking Trial Participants October 12, 2022
    The Pediatric Trials Network (PTN) has sent thank you cards to thousands of trial participants and their families this summer recognizing the critical role families play in advancing pediatric research. PTN has sent thank you notes domestically and internationally, translating the notes into foreign languages when appropriate. The thank you note is customized for each study ...
  • The Work of PTN Recently Highlighted by Clinical Pharmacology & Therapeutics September 8, 2022
    The work of the Pediatrics Trial Network (PTN) was recently highlighted in an editorial by the Editor-in Chief of Clinical Pharmacology & Therapeutics, Dr. Piet Hein van der Graaf of Leiden University. The editorial, which highlights examples of diversity in clinical pharmacology, features a PTN-led study and resulting publication titled: “Use of Real-World Data and Physiologically-Based ...
  • Raising Awareness for Pediatric Clinical Trials and Patient Engagement: PTN Presents at 2022 iCAN Research and Advocacy Summit July 13, 2022
    The Pediatric Trials Network (PTN) Project Team, along with global representatives from pharmaceutical and clinical research groups, recently participated in the annual International Children’s Advisory Network (iCAN) Research and Advocacy Summit in Lyon, France. iCAN is comprised of dedicated youth member groups that work in unison, around the world, to provide a voice for children and ...
 
 

News icon

news